Publikationen von Hannelore Ehrenreich

Ribbe, K.; Friedrichs, H.; Begemann, M.; Grube, S.; Papiol, S.; Kästner, A.; Gerchen, M. F.; Ackermann, V.; Tarami, A.; Treitz, A. et al.; Flögel, M.; Adler, L.; Aldenhoff, J. B.; Becker-Emner, M.; Becker, T.; Czernik, A.; Dose, M.; Folkerts, H.; Freese, R.; Guenther, R.; Herpertz, S.; Hesse, D.; Kruse, G.; Kunze, H.; Franz, M.; Lohrer, F.; Maier, W.; Mielke, A.; Müller-Isberner, R.; Oestereich, C.; Pajonk, F.-G.; Pollmächer, T.; Schneider, U.; Schwarz, H.-J.; Kröner-Herwig, B.; Havemann-Reinecke, U.; Frahm, J.; Stühmer, W.; Falkai, P.; Brose, N.; Nave, K.-A.; Ehrenreich, H.: The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients. BMC Psychiatry 10, 91 (2010)

Miskowiak, K. W.; Vinberg, M.; Harmer, C. J.; Ehrenreich, H.; Knudsen, G. M.; Macoveanu, J.; Hansen, A. R.; Paulson, O. B.; Siebner, H. R.; Kessing, L. V.: Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder. Trials 11 (1), 97 (2010)

Bartels, C.; Wegrzyn, M.; Wiedl, A.; Ackermann, V.; Ehrenreich, H.: Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing. BMC Neuroscience 11, 118 (2010)

Begemann, M.; Grube, S.; Papiol, S.; Malzahn, D.; Krampe, H.; Ribbe, K.; Friedrichs, H.; Radyushkin, K. A.; El-Kordi, A.; Benseler, F. et al.; Hannke, K.; Sperling, S.; Schwerdtfeger, D.; Thanhäuser, I.; Gerchen, M. F.; Ghorbani, M.; Gutwinski, S.; Hilmes, C.; Leppert, R.; Ronnenberg, A.; Sowislo, J.; Stawicki, S.; Stödtke, M.; Szuszies, C.; Reim, K.; Riggert, J.; Eckstein, F.; Falkai, P.; Bickeböller, H.; Nave, K.-A.; Brose, N.; Ehrenreich, H.: Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Archives of General Psychiatry 67 (9), S. 879 - 888 (2010)

Radyushkin, K.; El-Kordi, A.; Boretius, S.; Castaneda, S.; Ronnenberg, A.; Reim, K.; Bickeböller, H.; Frahm, J.; Brose, N.; Ehrenreich, H.: Complexin2 null mutation requires a ‘second hit’ for induction of phenotypic changes relevant to schizophrenia. Genes, Brain and Behavior 9 (6), S. 592 - 602 (2010)

Brzózka, M.; Radyushkin, K.; Wichert, S. P.; Ehrenreich, H.; Rossner, M. J.: Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain. Biological Psychiatry 68 (1), S. 33 - 40 (2010)

Ghezzi, P.; Bernaudin, M.; Bianchi, R.; Blomgren, K.; Brines, M.; Campana, W.; Cavaletti, G.; Cerami, A.; Chopp, M.; Coleman, T. et al.; Digicaylioglu, M.; Ehrenreich, H.; Erbayraktar, S.; Erbayraktar, Z.; Gassmann, M.; Genc, S.; Gokmen, N.; Grasso, G.; Juul, S.; Lipton, S. A.; Cerami Hand, C.; Latini, R.; Lauria, G.; Leist, M.; Newton, S. S.; Petit, E.; Probert, L.; Sfacteria, A.; Sirén, A.-L.; Talan, M.; Thiemermann, C.; Westenbrink, D.; Yaqoob, M.; Zhu, C.: Erythropoietin: not just about erythropoiesis. Lancet 375 (9732), S. 2142 - 2142 (2010)

Adamcio, B.; Sperling, S.; Hagemeyer, N.; Walkinshaw, G.; Ehrenreich, H.: Hypoxia inducible factor stabilization leads to lasting improvement of hippocampal memory in healthy mice. Behavioural Brain Research 208 (1), 10.1016/j.bbr.2009.11.010, S. 80 - 84 (2010)

Ehrenreich, H.; Bartels, C.; Weissenborn, K.; Diener, H.-C.: Response to the letter by Dame. Stroke 41 (3), S. e167 - e168 (2010)

Krampe, H.; Ehrenreich, H.: Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment. Current Pharmaceutical Design 16 (19), S. 2076 - 2090 (2010)

Sargin, D.; Friedrichs, H.; El-Kordi, A.; Ehrenreich, H.: Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research. Best Practice and Research Clinical Anaesthesiology 24 (4), S. 573 - 594 (2010)

Ehrenreich, H.; Weissenborn, K.; Prange, H.; Schneider, D.; Weimar, C.; Wartenberg, K.; Schellinger, P. D.; Bohn, M.; Becker, H.; Wegrzyn, M. et al.; Jähnig, P.; Herrmann, M.; Knauth, M.; Bähr, M.; Heide, W.; Wagner, A.; Schwab, S.; Reichmann, H.; Schwendemann, G.; Dengler, R.; Kastrup, A.; Bartels, C.: Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 40 (12), S. E647 - E656 (2009)

El-Kordi, A.; Radyushkin, K.; Ehrenreich, H.: Erythropoietin improves operant conditioning and stability of cognitive performance in mice. BMC Biology 7 (1), 37 (2009)

Radyushkin, K.; Hammerschmidt, K.; Boretius, S.; Varoqueaux, F.; El-Kordi, A.; Ronnenberg, A.; Winter, D.; Frahm, J.; Fischer, J.; Brose, N. et al.; Ehrenreich, H.: Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit. Genes, Brain and Behavior 8 (4), S. 416 - 425 (2009)

Hammerschmidt, K.; Radyushkin, K.; Ehrenreich, H.; Fischer, J.: Female mice respond to male ultrasonic 'songs' with approach behaviour. Biology Letters 5, S. 589 - 592 (2009)

Adamcio, B.; Havemann-Reinecke, U.; Ehrenreich, H.: Chronic psychosocial stress in the absence of social support induces pathological pre-pulse inhibition in mice. Behavioural Brain Research 204, 10.1016/j.bbr.2009.05.030, S. 246 - 249 (2009)

Binder, C.; Hagemann, T.; Sperling, S.; Schulz, M.; Pukrop, T.; Grimshaw, M. J.; Ehrenreich, H.: Stromal endothelin B receptor-deficiency inhibits breast cancer growth and metastasis. Molecular Cancer Therapeutics 8 (8), S. 2452 - 2460 (2009)

Reim, K.; Regus-Leidig, H.; Ammermüller, J.; El-Kordi, A.; Radyushkin, K.; Ehrenreich, H.; Brandstätter, J.; Brose, N.: Aberrant function and structure of retinal ribbon synapses in the absence of complexin 3 and complexin 4. Journal of Cell Science 122 (9), S. 1352 - 1361 (2009)

Sargin, D.; Hassouna, I.; Sperling, S.; Sirén, A.-L.; Ehrenreich, H.: Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion. GLIA 57 (7), S. 693 - 702 (2009)

Sirén, A.-L.; Faßhauer, T.; Bartels, C.; Ehrenreich, H.: Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics 6 (1), S. 108 - 127 (2009)